GURUFOCUS.COM » STOCK LIST » Technology » Software » Neurones (XPAR:NRO) » Definitions » Altman Z-Score

Neurones (XPAR:NRO) Altman Z-Score : 4.65 (As of May. 22, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Neurones Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 4.61 is strong.

Neurones has a Altman Z-Score of 4.65, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Neurones's Altman Z-Score or its related term are showing as below:

XPAR:NRO' s Altman Z-Score Range Over the Past 10 Years
Min: 3.6   Med: 4.16   Max: 5.08
Current: 4.61

During the past 13 years, Neurones's highest Altman Z-Score was 5.08. The lowest was 3.60. And the median was 4.16.


Neurones Altman Z-Score Historical Data

The historical data trend for Neurones's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurones Altman Z-Score Chart

Neurones Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.60 3.69 4.55 4.43 4.46

Neurones Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.55 - 4.43 - 4.46

Competitive Comparison of Neurones's Altman Z-Score

For the Information Technology Services subindustry, Neurones's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurones's Altman Z-Score Distribution in the Software Industry

For the Software industry and Technology sector, Neurones's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Neurones's Altman Z-Score falls into.



Neurones Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Neurones's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.47+1.4*0+3.3*0.1219+0.6*4.3109+1.0*1.0993
=4.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was €674.3 Mil.
Total Current Assets was €545.8 Mil.
Total Current Liabilities was €228.9 Mil.
Retained Earnings was €0.0 Mil.
Pre-Tax Income was €80.8 Mil.
Interest Expense was €-1.4 Mil.
Revenue was €741.2 Mil.
Market Cap (Today) was €1,148.2 Mil.
Total Liabilities was €266.3 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(545.813 - 228.923)/674.251
=0.47

X2=Retained Earnings/Total Assets
=0/674.251
=0

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(80.765 - -1.434)/674.251
=0.1219

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=1148.176/266.344
=4.3109

X5=Revenue/Total Assets
=741.175/674.251
=1.0993

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Neurones has a Altman Z-Score of 4.65 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Neurones  (XPAR:NRO) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Neurones Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Neurones's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurones (XPAR:NRO) Business Description

Traded in Other Exchanges
Address
Immeuble Le Clemenceau 1 - 205, Avenue Georges Clemenceau, Nanterre Cedex, Paris, FRA, 92024
Neurones SA is a France-based technology sector company. Its core business involves the provision of Information Technology (IT) services catering to the needs of hardware, software, and consulting. Its operations are thereby divided into three segments: Infrastructure Services, Application Services, and Consulting. The Infrastructure segment is the strongest revenue driver through the provision of such services as IT operations, IT service management, systems and network, server, application, and workstation outsourcing. Its second most profitable business is carried out through the Application segment, which entails SAP, Web and decision support, social media, data analysis.